Company page

Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc. (Ticker: VYGR) is a public company operating in the American market, with a market capitalization of approximately $211.5 million. The company focuses on developing gene therapies for neurological diseases. Voyager aims to leverage its innovative technology to address significant unmet medical needs in this field.